1319 studies found for:
melanoma
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
Characterization of the Melanoma-Specific Immune Response
|
||||
2 | Unknown † |
Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
|
||||
3 |
Completed
Has Results |
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
|
||||
4 |
Active, not recruiting
Has Results |
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
|
||||
5 | Recruiting |
Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
|
||||
6 | Completed |
Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
|
||||
7 | Active, not recruiting |
Melanoma Risk-Reduction Among Patients and Family Members
|
||||
8 | Active, not recruiting |
Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma
|
||||
9 |
Terminated
Has Results |
Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma
|
||||
10 | Not yet recruiting |
Melanoma Margins Excision Trial
|
||||
11 | Active, not recruiting |
Vaccination Plus Ontak in Patients With Metastatic Melanoma
|
||||
12 | Unknown † |
Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Who Have Undergone Surgery for Stage II, Stage III, or Stage IV Melanoma
|
||||
13 | Recruiting |
Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma
|
||||
14 | Completed |
Comparison of Video-Based Versus Written Patient Education on Melanoma
|
||||
15 | Unknown † |
Melanoma Vaccine in Treating Patients With Stage III Melanoma After Surgery to Remove Lymph Nodes
|
||||
16 | Unknown † |
Vaccine Therapy in Treating Patients With Metastatic Melanoma
|
||||
17 |
Completed
Has Results |
Peptide Vaccination for Patients at High Risk for Recurrent Melanoma
|
||||
18 | Recruiting |
Efficacy of Nilotinib in First or Second Line Treatment of Primary Melanomas Stage III Unresectable Melanomas.
|
||||
19 | Recruiting |
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients
|
||||
20 | Completed |
Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular Melanoma
|
† Indicates status has not been verified in more than two years